New bivalent COVID-19 Vaccines Have Been Approved By The FDA For Infants As Young As Six Months
Omicron-targeting bivalent COVID-19 vaccines have been approved for use in newborns as young as six months old, according to US Food and Drug Administration (FDA) announcement on Thursday.
FDA Commissioner Robert M. Califf, M.D, said…